Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
Rigouts L, Coeck N, Gumusboga M, de Rijk WB, Aung KJ, Hossain MA, Fissette K, Rieder HL, Meehan CJ, de Jong BC, Van Deun A.
Rigouts L, et al. Among authors: van deun a.
J Antimicrob Chemother. 2016 Feb;71(2):314-23. doi: 10.1093/jac/dkv360. Epub 2015 Nov 24.
J Antimicrob Chemother. 2016.
PMID: 26604243
Free PMC article.